-
Mashup Score: 4Login - 5 month(s) ago
New to DocMatter, or having trouble logging in? Click here to find your account Contact us for other issues, or Request to join.
Source: www.docmatter.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 6J&J CEO Says Weight-Loss Drug Market Is Too Crowded to Enter - 5 month(s) ago
Johnson & Johnson has no plans to start making weight-loss drugs because there’s already too much competition, according to Chief Executive Officer Joaquin Duato.
Source: www.bloomberg.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 4More Weight Loss With Mounjaro Than Ozempic: Data Analysis - 5 month(s) ago
Overweight or obese adults lost more weight and shed pounds faster using Eli Lilly’s Mounjaro than those taking Novo Nordisk’s popular rival weight loss drug.
Source: www.medscape.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0
Without financial help, workers say they can’t afford drug and expect weight and related health problems to return.
Source: www.startribune.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Pharmalittle: Biotech investors push to extend time before Medicare price negotiations; RiteAid closings could cause pharmacy deserts - 7 month(s) ago
Biopharma investors, who lobbied against allowing Medicare to negotiate drug prices, are trying a new tactic to preserve profits.
Source: www.statnews.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0UnitedHealth posts $5.8B in profit, $92.4B in revenue on Q3 beat - 7 month(s) ago
UnitedHealth Group kicked off another round of quarterly earnings calls Friday morning, when it reported $5.8 billion in profit for the third quarter. | UnitedHealth Group kicked off another round of quarterly earnings calls on Friday morning, where it reported $5.8 billion in profit for the third quarter.
Source: www.fiercehealthcare.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
GLP-1 drugs commonly used for weight loss management purposes can be a miracle solution for people who have struggled with their weight, but leaders at Solera Health say there are financial and hea | Solera Health’s step therapy program gives individuals personalized care to improve health conditions without GLP-1 drugs.
Source: www.fiercehealthcare.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Pharmalittle: People with obesity harmed by exclusion from studies; Teva sues Colorado over 'unconstitutional' program - 7 month(s) ago
People with obesity often go underrepresented in drug trials, a critical gap that researchers say leaves doctors unsure of efficacy or risks in that population.
Source: www.statnews.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1
When used to manage diabetes, glucagon-like peptide-1 (GLP-1) agonists confer excess risk for adverse gastrointestinal (GI) events, including
Source: www.jwatch.orgCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 0UnitedHealth wants to make weight loss drugs cheaper - 7 month(s) ago
UnitedHealth Group is pushing for lower prices for GLP-1 drugs like Ozempic and Wegovy, which are used to treat Type 2 diabetes and for weight loss.
Source: www.beckerspayer.comCategories: Healthcare Professionals, Latest HeadlinesTweet
A 66-year-old male who initially presented with low sodium, significant fatigue, and 30 pounds of unintentional #weightloss over six to seven months. While most symptoms have resolved, excessive burping continues. View the labs, then share your thoughts: https://t.co/CVXw6tmoKg